|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-1-31
|
|
pubmed:abstractText |
Neoadjuvant chemotherapy before cystectomy confers a survival benefit in bladder cancer, but it has not been widely adopted since most patients do not benefit and we are at present unable to predict those that do. Since the most important predictor of recurrence after cystectomy is pathologically positive nodes, our aim was to assess techniques that define this stage for the selection of patients for neoadjuvant chemotherapy.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1474-5488
|
|
pubmed:author |
pubmed-author:BarasAlexander SpyridonAS,
pubmed-author:DancikGarrettG,
pubmed-author:DingKuan-FuKF,
pubmed-author:FradetYvesY,
pubmed-author:HartmannArndtA,
pubmed-author:LeeJae KJK,
pubmed-author:LehmannJanJ,
pubmed-author:MoskalukChristopher ACA,
pubmed-author:RuYuanbinY,
pubmed-author:SmithSteven ChristopherSC,
pubmed-author:StöckleMichaelM,
pubmed-author:TheodorescuDanD
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
137-43
|
|
pubmed:dateRevised |
2011-8-15
|
|
pubmed:meshHeading |
pubmed-meshheading:21256081-Adult,
pubmed-meshheading:21256081-Aged,
pubmed-meshheading:21256081-Aged, 80 and over,
pubmed-meshheading:21256081-Female,
pubmed-meshheading:21256081-Gene Expression Profiling,
pubmed-meshheading:21256081-Humans,
pubmed-meshheading:21256081-Male,
pubmed-meshheading:21256081-Middle Aged,
pubmed-meshheading:21256081-Models, Genetic,
pubmed-meshheading:21256081-Neoadjuvant Therapy,
pubmed-meshheading:21256081-Neoplasm Staging,
pubmed-meshheading:21256081-Patient Care Planning,
pubmed-meshheading:21256081-Prospective Studies,
pubmed-meshheading:21256081-Urinary Bladder Neoplasms
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.
|
|
pubmed:affiliation |
Department of Surgery, University of Colorado, Aurora, CO, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
